Cargando…
Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?
The past decade saw the advent of a number of promising biomarkers to detect pregnancies at risk for preeclampsia (PE), the foremost being those associated with an imbalance of angiogenic factors. In late pregnancy, these are useful for the detection of imminent cases of PE, while earlier they were...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Informa Healthcare
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673513/ https://www.ncbi.nlm.nih.gov/pubmed/25774007 http://dx.doi.org/10.1586/14737159.2015.1025757 |